Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

November 11, 2019

Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that the U.S. Food and Drug Administration (FDA) has reviewed and cleared the Investigational New Drug Application (IND) for ACH-5228, the Company’s second-generation oral factor D inhibitor.
More »

Bempedoic Acid Included in Top 10 Medical Innovations for 2020 List

October 25, 2019

Esperion (NASDAQ:ESPR) announced that bempedoic acid was included in the “Top 10 Medical Innovations for 2020” at Cleveland Clinic’s 2019 Medical Innovation Summit on Wednesday, October 23rd.
More »

Obalon Announces First Patient Treatments at its First Company Owned Center for Weight Loss

October 22, 2019

Obalon Therapeutics, Inc. (NASDAQ:OBLN), announces it has treated the first patients at its Company-owned weight loss treatment center, the Obalon Center for Weight Loss, in San Diego, California.
More »